-
DOI: 10.1099/ijs.0.02873-0
Derrien M, Vaughan EE, Plugge CM, de Vos WM
(2004).
Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.
-
DOI: 10.1371/journal.pone.0071108
Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L
(2013).
Human gut microbiota changes reveal the progression of glucose intolerance.
-
DOI: 10.1111/jam.13022
Guo X, Zhang J, Wu F, Zhang M, Yi M, Peng Y
(2016).
Different subtype strains of Akkermansia muciniphila abundantly colonize in southern China.
-
DOI: 10.1080/19490976.2018.1511663
Ring C, Klopfleisch R, Dahlke K, Basic M, Bleich A, Blaut M
(2018).
Akkermansia muciniphila strain ATCC BAA-835 does not promote short-term intestinal inflammation in gnotobiotic interleukin-10-deficient mice.
-
DOI: 10.3389/fcimb.2019.00239
Zhai R, Xue X, Zhang L, Yang X, Zhao L, Zhang C
(2019).
Strain-Specific Anti-inflammatory Properties of Two Akkermansia muciniphila Strains on Chronic Colitis in Mice.
-
DOI: 10.1016/j.anaerobe.2019.102138
Wu F, Guo X, Zhang M, Ou Z, Wu D, Deng L, Lu Z, Zhang J, Deng G, Chen S, Li S, Yi J, Peng Y
(2019).
An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice.
-
DOI: 10.1016/j.ijbiomac.2020.01.246
Kosciow K, Deppenmeier U
(2020).
Characterization of three novel beta-galactosidases from Akkermansia muciniphila involved in mucin degradation.
-
DOI: 10.1016/j.enzmictec.2020.109568
Zhang X, Sheng W, Li K, Rong Y, Wu Q, Meng Q, Kong Y, Chen M
(2020).
Substrate specificity of the galactokinase from the human gut symbiont Akkermansia muciniphila ATCC BAA-835.
-
DOI: 10.3389/fcimb.2021.698914
Liu Q, Lu W, Tian F, Zhao J, Zhang H, Hong K, Yu L
(2021).
Akkermansia muciniphila Exerts Strain-Specific Effects on DSS-Induced Ulcerative Colitis in Mice.
-
DOI: 10.1002/pmic.202100125
Lee JY, Jin HS, Kim KS, Baek JH, Kim BS, Lee DW
(2021).
Nutrient-specific proteomic analysis of the mucin degrading bacterium Akkermansia muciniphila.
-
DOI: 10.1093/glycob/cwac027
Garcia-Vello P, Tytgat HLP, Gray J, Elzinga J, Di Lorenzo F, Biboy J, Vollmer D, De Castro C, Vollmer W, de Vos WM, Molinaro A
(2022).
Peptidoglycan from Akkermansia muciniphila MucT: chemical structure and immunostimulatory properties of muropeptides.
-
DOI: 10.3390/cells11132084
Kumar R, Kane H, Wang Q, Hibberd A, Jensen HM, Kim HS, Bak SY, Auzanneau I, Bry S, Christensen N, Friedman A, Rasinkangas P, Ouwehand AC, Forssten SD, Hasselwander O
(2022).
Identification and Characterization of a Novel Species of Genus Akkermansia with Metabolic Health Effects in a Diet-Induced Obesity Mouse Model.
-
DOI: 10.1038/s41598-022-23980-6
Filardi R, Gargari G, Mora D, Arioli S
(2022).
Characterization of antibiotic-resistance traits in Akkermansia muciniphila strains of human origin.
-
DOI: 10.1038/s41598-022-25873-0
Ndongo S, Armstrong N, Raoult D, Fournier PE
(2022).
Reclassification of eight Akkermansia muciniphila strains and description of Akkermansia massiliensis sp. nov. and Candidatus Akkermansia timonensis, isolated from human feces.
-
DOI: 10.1080/19490976.2021.1880240
Higarza SG, Arboleya S, Arias JL, Gueimonde M, Arias N
(2021).
Akkermansia muciniphila and environmental enrichment reverse cognitive impairment associated with high-fat high-cholesterol consumption in rats.